MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-02-2023
NuVasive Operating Expenses 2011-2026 | NUVA
Annual Operating Expenses NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 777 M | 829 M | 691 M | 735 M | 688 M | 638 M | 624 M | 513 M | 521 M | 472 M | 420 M | 394 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 829 M | 394 M | 608 M |
Quarterly Operating Expenses NuVasive
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 210 M | 214 M | - | 193 M | 192 M | 200 M | - | 189 M | 206 M | 187 M | - | 184 M | 160 M | 160 M | - | 183 M | 184 M | 180 M | - | 179 M | 176 M | 205 M | - | 151 M | 164 M | 165 M | - | 159 M | 116 M | 149 M | - | 123 M | 129 M | 91.2 M | - | 126 M | 141 M | 162 M | - | 114 M | 117 M | 114 M | - | 98.1 M | 105 M | 108 M | - | 198 M | 96 M | 96.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 214 M | 91.2 M | 156 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.19 B | $ 185.02 | -0.81 % | $ 13.9 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 38.94 | -1.37 % | $ 5.8 K | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.58 | -0.55 % | $ 1.7 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.61 | 3.18 % | $ 38 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.59 | 1.99 % | $ 134 M |  France |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 63.42 | -1.83 % | $ 93.9 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 10.5 | 0.38 % | $ 297 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
40.3 M | $ 25.39 | -1.24 % | $ 215 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.8 | -7.2 % | $ 69.4 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.53 | -7.39 % | $ 388 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 92.76 | -1.87 % | $ 12.5 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.06 | 6.19 % | $ 1.25 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 5.29 | 8.74 % | $ 1.12 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.59 | 6.29 % | $ 175 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.04 | - | $ 17.6 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.83 | -1.46 % | $ 388 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 56.45 | -0.34 % | $ 1.66 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 37.91 | -3.88 % | $ 1.18 B | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 65.01 | -0.2 % | $ 3.55 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 88.37 | 0.49 % | $ 3.07 B | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.76 | -0.05 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 79.05 | 1.09 % | $ 46.2 B | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.68 | -2.19 % | $ 7.43 M | USA |
 |
Penumbra
PEN
|
753 M | $ 331.47 | -0.29 % | $ 12.9 B | USA |